Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 2/20 | 0.44 |
| ▸ | FNTB | P49356 | 2/20 | 0.44 |
| ▸ | CPA3 | P15088 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3385428 | 1.00 | FNTA (0.44) | FNTAFNTBCPA3FOLH1MME | |
| SCHEMBL3385432 | 1.00 | FNTA (0.44) | FNTAFNTBCPA3FOLH1MME | |
| SCHEMBL2052734 | 1.00 | FNTA (0.44) | FNTAFNTBCPA3FOLH1MME | |
| Hydrochloric Acid SCHEMBL30361277 | 0.98 | FNTA (0.43) | FNTAFNTBCPA3FOLH1MME | |
| Sulfuric Acid SCHEMBL29009443 | 0.91 | MME (0.42) | FNTAFNTBCPA3FOLH1MME | |
| SCHEMBL31530762 | 0.85 | GAA (0.43) | FOLH1THRBALOX15RECQLCA12 | |
| SCHEMBL30826532 | 0.83 | CA2 (0.43) | FNTAFNTBMMEKDM4EMAPT | |
| SCHEMBL2322992 | 0.83 | ACE (0.45) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL2418011 | 0.82 | KDM4E (0.40) | FNTAFNTBMMEKDM4EMAPT | |
| SCHEMBL7067906 | 0.82 | KMT2A (0.46) | THRBCA12CA9GAAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112972395-B | Capsule preparation and preparation method and application thereof | 湖北舒邦药业有限公司 | 2022-12-13 | — | — | CN | claimed |
| WO-2013001167-A1 | NON-TOXIC COMPOSITIONS FOR DECREASING THE RISK OF CANCER CAUSED BY ORAL MICROBES | BIOHIT OYJ (FI) | 2013-01-03 | — | — | WO | claimed |
| EP-1904515-B1 | SIDE-CHAIN EXTENDED LIGATION | AMYLIN PHARMACEUTICALS INC (US) | 2010-12-08 | — | — | EP | claimed |
| US-20090192300-A1 | Side-Chain Extended Ligation | GENEPROT INC. (CH) | 2009-07-30 | — | — | US | claimed |
| EP-1904515-A1 | SIDE-CHAIN EXTENDED LIGATION | Amylin Pharmaceuticals, Inc. (US) | 2008-04-02 | — | — | EP | claimed |
| WO-2006133962-A1 | SIDE-CHAIN EXTENDED LIGATION | AMYLIN PHARMACEUTICALS, INC. (US) | 2006-12-21 | — | — | WO | claimed |
| JP-11335351-A | — | — | None | — | — | JP | disclosed |
| EP-4467640-A1 | MICROORGANISM AND METHOD FOR THE IMPROVED PRODUCTION OF CYSTEINE AND/OR DERIVATIVES THEREOF | Metabolic Explorer (FR) | 2024-11-27 | — | — | EP | disclosed |
| US-11643676-B2 | In vitro glycosylation of proteins and enzymes | Design-Zyme LLC (US) | 2023-05-09 | — | — | US | disclosed |
| CN-112972395-B | Capsule preparation and preparation method and application thereof | 湖北舒邦药业有限公司 | 2022-12-13 | — | — | CN | disclosed |
| US-20190038611-A1 | Novel CYP34A-Specific Inhibitors and Methods of Using Same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-02-07 | — | — | US | disclosed |
| US-20190038611-A1 | Novel CYP34A-Specific Inhibitors and Methods of Using Same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-02-07 | — | — | US | disclosed |
| CN-107690281-A | Cystic fibrosis transmembrane transduction modulator modulators | 弗特克斯药品有限公司 | 2018-02-13 | — | — | CN | disclosed |
| EP-0425212-A2 | Cyclic anti-aggregatory peptides | SMITHKLINE BEECHAM CORPORATION (US) | 1991-05-02 | — | — | EP | disclosed |
| US-4841049-A | FOR CELLULOSIC FIBERS; BRIGHT BLUE COLORS; WET- AND LIGHTFAST | CIBA-GEIGY CORPORATION (US) | 1989-06-20 | — | — | US | disclosed |
| US-4652634-A | Water-soluble monoazo compounds containing a N-(sulfoalkyl)-aniline coupling component and a fiber-reactive group of the vinylsulfonyl series in the phenyl or benzothiazole diazo component, suitable as fiber-reactive dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-03-24 | — | — | US | disclosed |
| US-4430259-A | Water-soluble disazo compounds suitable as fiber-reactive dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-02-07 | — | — | US | disclosed |
| WO-1982003860-A1 | DERIVATIVES OF 1,4-THIAZANE-CARBOXYLIC ACID,PREPARATION AND UTILIZATION THEREOF AND COMPOSITIONS CONTAINING SAME | GILLET CLAUDE | 1982-11-11 | — | — | WO | disclosed |
| US-4283196-A | FIXING BY ACTION OF AN ALKALINE AGENT | AMERICAN HOECHST CORPORATION (US) | 1981-08-11 | — | — | US | disclosed |
| US-4271072-A | FIBER-REACTIVE, FOR DYEING NATURAL AND SYNTHETIC POLYAMIDES AND CELULOSES | AMERICAN HOECHST CORPORATION (US) | 1981-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190038611-A1 | Novel CYP34A-Specific Inhibitors and Methods of Using Same | CYP3A43, CYP3A4, CYP4B1 | FNTA 356/4885FNTB 609/4885CPA3 265/4885 |
| US-20090192300-A1 | Side-Chain Extended Ligation | CTH, BCAT1, LNPEP | FNTA 367/4885FNTB 409/4885CPA3 772/4885 |
| US-11643676-B2 | In vitro glycosylation of proteins and enzymes | ALDH7A1, OGA, DAO | FNTA 2070/4885FNTB 1354/4885CPA3 2581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.